Healthcare & Life Sciences
Turning Point Therapeutics
United Stateswww.tptherapeutics.com/
series-c-plus
series-c-plus
Stage
2
Investors
About
Turning Point Therapeutics is a clinical-stage biotechnology company focused on developing precision oncology therapies targeting genetically defined tumors in cancer patients.
Explore Turning Point Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.